Filtered By:
Specialty: Cardiology
Procedure: Heart Valve Surgery
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 1031 results found since Jan 2013.
Transcatheter Aortic Valve Implantation: Transvascular Is the Way to Go!
There is no doubt that transcatheter aortic valve implantation (TAVI) has been widely accepted by the whole medical community dedicated to the heart care of patients with aortic valve stenosis. Increasing clinical experience and constant refinement of devices and procedural techniques have resulted in improved outcomes, especially since the generalized use of the transfemoral approach for TAVI.1 So far, only transfemoral TAVI has been associated with a significant reduction of mortality or disabling stroke in patients at intermediate risk, compared with surgical aortic valve replacement (AVR).
Source: The American Journal of Cardiology - July 1, 2023 Category: Cardiology Authors: Thierry Bov é Tags: Editorial Source Type: research
Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device
The Sentinel cerebral embolic protection device (CEP) aims to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). We performed a systematic review and meta-analysis of propensity sc...
Source: BMC Cardiovascular Disorders - June 17, 2023 Category: Cardiology Authors: Mathias Wolfrum, Immanuel Justus Handerer, Federico Moccetti, Alexander Schmeisser, Ruediger C. Braun-Dullaeus and Stefan Toggweiler Tags: Research Source Type: research
Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression
CONCLUSIONS: TAVI demonstrated an increasing trend of all-cause mortality compared with SAVR when evaluated over a long-term follow-up. More long-term data from recent studies using newer-generation valves and state-of-the-art techniques are needed to accurately assign risks.PMID:37294002 | DOI:10.1080/00015385.2023.2218025
Source: Acta Cardiologica - June 9, 2023 Category: Cardiology Authors: Dae Yong Park Seokyung An Kameel Kassab Neeraj Jolly Steve Attanasio Ray Sawaqed Saurabh Malhotra Rami Doukky Aviral Vij Source Type: research
Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry
ConclusionsBail-out TAVI-in-TAVI is associated with significant early and long-term mortality and morbidity. Thus, meticulous preprocedural planning and sophisticated intraprocedural techniques are of paramount importance to avoid these emergency procedures.
Source: Clinical Research in Cardiology - June 9, 2023 Category: Cardiology Source Type: research
Rescue aortic valvuloplasty for severe aortic stenosis is simple and effective in severely hemodynamically compromised patients presenting to centers without on-site heart surgery or TAVI facilities
AbstractManagement of high-risk patients with severe aortic stenosis (AS) is a challenging issue. The prognosis of patients with AS presenting with therapy-refractory pulmonary edema (RPE) or cardiogenic shock (CS) remains poor. The purpose of this study was to assess the 30-day mortality of rescue percutaneous balloon aortic valvuloplasty (PBAV) in AS patients presenting with RPE or CS in a community-based hospital without on- site heart surgery. From January 2016 to February 2019, we identified consecutively admitted patients with CS or RPE related to severe AS who underwent emergent PBAV. The primary end...
Source: Heart and Vessels - May 30, 2023 Category: Cardiology Source Type: research
Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial
CONCLUSIONS: For patients with severe aortic stenosis and low surgical risk similar to those enrolled in the PARTNER 3 trial, transfemoral TAVR with the SAPIEN 3 valve is cost saving compared with SAVR at 2 years and is projected to be economically attractive in the long run as long as there are no substantial differences in late death between the 2 strategies. Long-term follow-up will be critical to ultimately determine the preferred treatment strategy for low-risk patients from both a clinical and economic perspective.PMID:37154049 | DOI:10.1161/CIRCULATIONAHA.122.062481
Source: Circulation - May 8, 2023 Category: Cardiology Authors: Benjamin Z Galper Khaja M Chinnakondepalli Kaijun Wang Elizabeth A Magnuson Michael Lu Vinod H Thourani Susheel Kodali Raj Makkar Howard C Herrmann Samir Kapadia Mathew Williams John Webb Craig R Smith Michael J Mack Martin B Leon David J Cohen PARTNER In Source Type: research
Vascular access for Transcatheter aortic valve replacement: A network Meta-analysis
CONCLUSION: In patients who underwent TF, Tsc, TC, or Tcav TAVR, Tsc had a higher rate of stroke compared to TF and Tcav, and major or life-threatening bleeding compared to TF. The rate of major vascular complications in Tcav was the highest among the four approaches.PMID:37116649 | DOI:10.1016/j.jjcc.2023.04.015
Source: Journal of Cardiology - April 28, 2023 Category: Cardiology Authors: Yujiro Yokoyama Tomoki Sakata Takahisa Mikami Naoki Misumida Andrea Scotti Hisato Takagi Tadahisa Sugiura Toshiki Kuno Azeem Latib Source Type: research
Transcatheter Aortic Valve Replacement for Aortic Valve Infective Endocarditis: A Systematic Review and Call for Action
AbstractWe aimed to systematically analyze the literature on the use of transcatheter aortic valve replacement (TAVR) to treat active aortic valve infective endocarditis (AV-IE). Surgery is declined in one-third of patients with IE who meet indications because of prohibitive surgical risk. TAVR might be an alternative for selected patients with AV-IE as a bridge-to-surgery or stand-alone therapy. PubMed/MEDLINE, Embase, and Cochrane databases were searched (2002 –2022) for studies on TAVR use in active AV-IE. Of 450 identified reports, six met inclusion criteria (all men, mean age 71 ± 12 years, median Society of T...
Source: Cardiology and Therapy - April 20, 2023 Category: Cardiology Source Type: research
